These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 26015199

  • 21. Randomized clinical trials: prescriptions to be applied with caution!
    Alderman MH.
    Am J Hypertens; 2008 May; 21(5):483-4. PubMed ID: 18437132
    [No Abstract] [Full Text] [Related]

  • 22. [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].
    El Aassri H, El Mghari G, El Ansari N.
    Pan Afr Med J; 2014 May; 17():193. PubMed ID: 25396019
    [Abstract] [Full Text] [Related]

  • 23. Intensive glucose control in type 2 diabetes.
    Parashar A.
    N Engl J Med; 2008 Oct 02; 359(14):1520; author reply 1520-1. PubMed ID: 18837128
    [No Abstract] [Full Text] [Related]

  • 24. Blood pressure control in type 2 diabetes.
    de Galan BE.
    N Engl J Med; 2010 Aug 12; 363(7):695-6; author reply 697. PubMed ID: 20842774
    [No Abstract] [Full Text] [Related]

  • 25. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 12; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 26. Hypertension: a review and rationale of treatment.
    Copley JB, Rosario R.
    Dis Mon; 2005 Mar 12; 51(10-11):548-614. PubMed ID: 16360376
    [No Abstract] [Full Text] [Related]

  • 27. Meeting of the minds. Should pre-hypertension in type 2 diabetes be treated?
    Bihl G, Amod A, Ellis G, Moore R, Raal FJ, Gernholtz T, Schamroth C, Horak A.
    Cardiovasc J Afr; 2010 Mar 12; 21(3 Suppl):S9-S13. PubMed ID: 20532426
    [No Abstract] [Full Text] [Related]

  • 28. [Diuretic therapy of hypertensives with Type 2 diabetes; rational therapy or malpractice?].
    Schäfers RF, Lütkes P, Philipp T.
    Ther Umsch; 2000 Jun 12; 57(6):368-73. PubMed ID: 10894021
    [Abstract] [Full Text] [Related]

  • 29. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun 12; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 30. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
    Stolk RP, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Juming L, Patel A, Thom SA, Grobbee DE, AdRem project team and ADVANCE management committee.
    Contemp Clin Trials; 2007 Jan 12; 28(1):6-17. PubMed ID: 17030155
    [Abstract] [Full Text] [Related]

  • 31. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
    Niskanen L, Uusitupa M, Laakso M.
    Duodecim; 1999 Jan 12; 115(10):1122-4. PubMed ID: 11877851
    [No Abstract] [Full Text] [Related]

  • 32. Endothelial dysfunction and hypertension in diabetes mellitus.
    Dandona P, Chaudhuri A, Aljada A.
    Med Clin North Am; 2004 Jul 12; 88(4):911-31, x-xi. PubMed ID: 15308385
    [Abstract] [Full Text] [Related]

  • 33. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?].
    Zidek W.
    MMW Fortschr Med; 2004 Jan 15; 146(1-2):37-8. PubMed ID: 18437867
    [No Abstract] [Full Text] [Related]

  • 34. Medication adherence affects treatment modifications in patients with type 2 diabetes.
    Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P, Groningen Initiative to Analyze Type 2 Diabetes Treatment Group.
    Clin Ther; 2011 Jan 15; 33(1):121-34. PubMed ID: 21397778
    [Abstract] [Full Text] [Related]

  • 35. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A.
    Nephrologie; 2000 Jan 15; 21(4):203-4. PubMed ID: 10976435
    [No Abstract] [Full Text] [Related]

  • 36. Implications of the ADVANCE study for clinical practice.
    Zannad F.
    J Hypertens Suppl; 2008 Sep 15; 26(3):S29-32. PubMed ID: 19363850
    [Abstract] [Full Text] [Related]

  • 37. [Therapy of hypertension in elderly patients with multiple morbidity].
    Slany J.
    Wien Med Wochenschr; 2004 Sep 15; 154 Spec No 1(1):4-6. PubMed ID: 15346545
    [No Abstract] [Full Text] [Related]

  • 38. [Hypertension plus diabetes. Lowering blood pressure is first priority].
    MMW Fortschr Med; 1999 Sep 23; 141(38):55. PubMed ID: 10904621
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of hypertensive type 2 diabetics: too late, too little].
    Holzgreve H.
    Herz; 2008 Apr 23; 33(3):191-5. PubMed ID: 18568313
    [Abstract] [Full Text] [Related]

  • 40. Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study.
    Laakso M.
    Circulation; 1999 Feb 02; 99(4):461-2. PubMed ID: 9927388
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.